Common Stock, Shares, Issued of REGENERX BIOPHARMACEUTICALS INC from Q4 2010 to Q1 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
REGENERX BIOPHARMACEUTICALS INC quarterly Common Stock, Shares, Issued history and change rate from Q4 2010 to Q1 2023.
  • REGENERX BIOPHARMACEUTICALS INC Common Stock, Shares, Issued for the quarter ending 31 Mar 2023 was 143,549,735, unchanged year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

REGENERX BIOPHARMACEUTICALS INC Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2023 143,549,735 0 0% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 143,549,735 0 0% 31 Dec 2022 10-Q 15 May 2023 2023 Q1
Q3 2022 143,549,735 0 0% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 143,549,735 +102,947 +0.07% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 143,549,735 +10,002,947 +7.5% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 143,549,735 +10,107,947 +7.6% 31 Dec 2021 10-K 11 Apr 2023 2022 FY
Q3 2021 143,549,735 +10,107,957 +7.6% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 143,446,788 +10,005,010 +7.5% 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 133,546,788 +105,010 +0.08% 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 133,441,788 +1,935,294 +1.5% 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 133,441,778 +1,935,284 +1.5% 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 133,441,778 +1,935,284 +1.5% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 133,441,778 +2,935,284 +2.2% 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 131,506,494 +3,074,016 +2.4% 31 Dec 2019 10-K 02 Mar 2021 2020 FY
Q3 2019 131,506,494 +3,074,016 +2.4% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 131,506,494 +11,869,212 +9.9% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 130,506,494 +10,869,212 +9.1% 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 128,432,478 +18,642,775 +17% 31 Dec 2018 10-K 20 Mar 2020 2019 FY
Q3 2018 128,432,478 +21,549,719 +20% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 119,637,282 +12,754,523 +12% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 119,637,282 +12,850,131 +12% 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 109,789,703 +3,002,552 +2.8% 31 Dec 2017 10-K 29 Mar 2019 2018 FY
Q3 2017 106,882,759 +95,608 +0.09% 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 106,882,759 +95,608 +0.09% 30 Jun 2017 10-Q 21 Aug 2017 2017 Q2
Q1 2017 106,787,151 +5,147,059 +5.1% 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 106,787,151 +5,147,059 +5.1% 31 Dec 2016 10-K 29 Mar 2018 2017 FY
Q3 2016 106,787,151 +5,147,059 +5.1% 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 106,787,151 +5,147,059 +5.1% 30 Jun 2016 10-Q 22 Aug 2016 2016 Q2
Q1 2016 101,640,092 +323,512 +0.32% 31 Mar 2016 10-Q 16 May 2016 2016 Q1
Q4 2015 101,640,092 +323,512 +0.32% 31 Dec 2015 10-K 29 Mar 2017 2016 FY
Q3 2015 101,640,092 +323,512 +0.32% 30 Sep 2015 10-Q 13 Nov 2015 2015 Q3
Q2 2015 101,640,092 +8,656,845 +9.3% 30 Jun 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 101,316,580 +8,333,333 +9% 31 Mar 2015 10-Q 15 May 2015 2015 Q1
Q4 2014 101,316,580 +19,583,333 +24% 31 Dec 2014 10-K 11 Apr 2016 2015 FY
Q3 2014 101,316,580 +19,583,333 +24% 30 Sep 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 92,983,247 +11,250,000 +14% 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 92,983,247 +11,250,000 +14% 31 Mar 2014 10-Q 15 May 2014 2014 Q1
Q4 2013 81,733,247 0 0% 31 Dec 2013 10-K 31 Mar 2015 2014 FY
Q3 2013 81,733,247 0 0% 30 Sep 2013 10-Q 18 Nov 2013 2013 Q3
Q2 2013 81,733,247 +54,167 +0.07% 30 Jun 2013 10-Q 14 Aug 2013 2013 Q2
Q1 2013 81,733,247 +342,629 +0.42% 31 Mar 2013 10-Q 15 May 2013 2013 Q1
Q4 2012 81,733,247 +342,629 +0.42% 31 Dec 2012 10-K 04 Apr 2014 2013 FY
Q3 2012 81,733,247 +1,157,510 +1.4% 30 Sep 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 81,679,080 +1,717,178 +2.1% 30 Jun 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 81,390,618 31 Mar 2012 10-Q 15 May 2012 2012 Q1
Q4 2011 81,390,618 +7,859,040 +11% 31 Dec 2011 10-K 16 Apr 2013 2012 FY
Q3 2011 80,575,737 30 Sep 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 79,961,902 30 Jun 2011 10-Q 05 Aug 2011 2011 Q2
Q4 2010 73,531,578 31 Dec 2010 10-K 04 Apr 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.